ConductScience.org, home

Paper42236660

Advancing transdermal drug delivery using translational data and mechanistic based modeling.

Rose JP and 5 others. Drug Deliv Transl Res, 2026. Cited by 0 papers, by iCite.

Cite this record

ConductScience Library. Advancing transdermal drug delivery using translational data and mechanistic based modeling. Papers, record 42236660. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/42236660

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Advancing transdermal drug delivery using translational data and mechanistic based modeling.
PubMed
Journal
Drug Deliv Transl Res
PubMed
Year
2026
PubMed
Publication types
Journal Article
PubMed
Citations, by iCite
0
iCite
Revised in PubMed
2026-06-03
PubMed

Authors6

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Rose JPJohn P
2Shrestha NNisha
3Patil YPYogesh Prakash
4Tan JSJeffrey S
5Bharadwaj RReshma
6Subramony JAJ Anand

Source PubMed

Download CSV of authors

Topics0

NLM's MeSH indexing of the paper, its major topics first.

None in this release.

References67

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
134321111Recent advances in transdermal drug delivery systems: a review.Biomater Res2021https://conductscience.org/library/papers/34321111PubMed
228647443Dermal and transdermal delivery of pharmaceutically relevant macromolecules.Eur J Pharm Biopharm2017https://conductscience.org/library/papers/28647443PubMed
330981946Development and in vitro evaluation of pressure sensitive adhesive patch for the transdermal delivery of galantamine: Effect of penetration enhancers and crystallization inhibition.Eur J Pharm Biopharm2019https://conductscience.org/library/papers/30981946PubMed
418417307Formulation and biopharmaceutical evaluation of transdermal patch containing benztropine.Int J Pharm2008https://conductscience.org/library/papers/18417307PubMed
515661573Development of a novel prolonged-release nicotine transdermal patch.Pharmacol Res2005https://conductscience.org/library/papers/15661573PubMed
626288995Formulation optimization of a drug in adhesive transdermal analgesic patch.Drug Dev Ind Pharm2016https://conductscience.org/library/papers/26288995PubMed
728540770Transdermal estrogens in the changing landscape of hormone replacement therapy.Postgrad Med2017https://conductscience.org/library/papers/28540770PubMed
819876859Transdermal fentanyl: pharmacology and toxicology.J Med Toxicol2009https://conductscience.org/library/papers/19876859PubMed
925560046Transdermal patches: history, development and pharmacology.Br J Pharmacol2015https://conductscience.org/library/papers/25560046PubMed
1023419814The transdermal delivery of fentanyl.Eur J Pharm Biopharm2013https://conductscience.org/library/papers/23419814PubMed
1110668859Clinical pharmacokinetics of transdermal opioids: focus on transdermal fentanyl.Clin Pharmacokinet2000https://conductscience.org/library/papers/10668859PubMed
1215040576Current status and future potential of transdermal drug delivery.Nat Rev Drug Discov2004https://conductscience.org/library/papers/15040576PubMed
1326506371Transdermal Drug Delivery: Innovative Pharmaceutical Developments Based on Disruption of the Barrier Properties of the stratum corneum.Pharmaceutics2015https://conductscience.org/library/papers/26506371PubMed
165910974The permeability of mammalian skin to ions.J Invest Dermatol1966https://conductscience.org/library/papers/5910974PubMed
1722261307Application of numerical methods for diffusion-based modeling of skin permeation.Adv Drug Deliv Rev2013https://conductscience.org/library/papers/22261307PubMed
1821356301Mathematical models of skin permeability: an overview.Int J Pharm2011https://conductscience.org/library/papers/21356301PubMed
1923142646Detailed modeling of skin penetration--an overview.Adv Drug Deliv Rev2013https://conductscience.org/library/papers/23142646PubMed
208692735Non steady-state descriptions of drug permeation through stratum corneum. I. The biphasic brick-and-mortar model.Pharm Res1996https://conductscience.org/library/papers/8692735PubMed
2118093598Using the method of homogenization to calculate the effective diffusivity of the stratum corneum with permeable corneocytes.J Biomech2008https://conductscience.org/library/papers/18093598PubMed
2217876780A multiphase microscopic diffusion model for stratum corneum permeability. II. Estimation of physicochemical parameters, and application to a large permeability database.J Pharm Sci2007https://conductscience.org/library/papers/17876780PubMed

See all 67 referencesDownload CSV of references

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Grants
  • Trials
  • Comments and corrections
  • Cited by
  • Genes
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/42236660

GET https://conductscience.org/api/papers/v1/42236660/references?page=2